Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
Karyopharm Therapeutics (KPTI)
- 8.900
- +0.050+0.56%
Close May 14 16:00 ET
- 8.710
- -0.190-2.13%
Post 16:30 ET
200.71MMarket Cap-0.50P/E (TTM)
10.230High8.700Low1.01MVolume9.525Open8.850Prev Close9.27MTurnover5.44%Turnover RatioLossP/E (Static)22.55MShares10.99052wk High-0.69P/B165.05MFloat Cap3.65052wk Low--Dividend TTM18.54MShs Float735.075Historical High--Div Yield TTM17.29%Range %3.510Historical Low9.196Avg Price1Lot Size
Karyopharm Therapeutics (KPTI) Key Financial Indicators
KPTI Earnings per Share (EPS)
According to the latest financial report of Karyopharm Therapeutics, the latest earnings per share (TTM) for the company is -5.71. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
KPTI Free Cash Flow (FCF)
Interested in knowing about Karyopharm Therapeutics's free cash flow? The latest report shows it as -11.83M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
KPTI Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Karyopharm Therapeutics shows that the company's current ratio is 1.12, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
KPTI Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Karyopharm Therapeutics, the quick ratio is 0.98, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
KPTI Return on Equity (ROE)
Want to learn more about the financial health of Karyopharm Therapeutics? The latest ROE figure is -1.05K%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
KPTI Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Karyopharm Therapeutics, the total asset return on investment (ROA) is -99.88%.
Currency: USD
Quarterly
Loading...
KPTI Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Karyopharm Therapeutics's latest financial report to see how their gross margin is doing - currently at 95.65%.
Currency: USD
Quarterly
Loading...
KPTI Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Karyopharm Therapeutics, the net profit margin is -299.89%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm